Published 60 Day FRN

33464

Federal Register / Vol. 77, No. 109 / Wednesday, June 6, 2012 / Notices
TABLE 1—ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(in hours)

Total burden
hours

Form

1. Individuals in households ..............
2. Individuals in households ..............

NHANES Questionnaire ....................
Special Studies ..................................

3,850
1,000

1
1

2.4
3

9,240
3,000

Total ............................................

............................................................

........................

........................

......................

12,240

Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–13686 Filed 6–5–12; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–12–0824]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

mstockstill on DSK4VPTVN1PROD with NOTICES

Number of
respondents

Type of respondent

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.

VerDate Mar<15>2010

17:24 Jun 05, 2012

Jkt 226001

Proposed Project
BioSense 2.0 (OMB No. 0920–0824,
exp. 10/31/2012)—Revision—Office of
Surveillance, Epidemiology, and
Laboratory Services (OSELS), Public
Health Surveillance and Informatics
Program Office (PHSIPO) {Proposed}
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description:
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002,
and it was launched by the Centers for
Disease Control and Prevention (CDC) in
2003. BioSense is a near real-time
surveillance system that receives and
processes electronic healthcare
encounter data, including, chief
complaints, final diagnosis codes,
procedure codes, clinical laboratory,
pharmacy prescription, and patient
demographic data from participating
public health jurisdictions’ non-federal
hospital emergency departments and
inpatient facilities in addition to all
United States Department of Defense
(DoD) and Veterans Affairs (VA)
outpatient hospitals and clinics
nationwide. The BioSense Program also
receives pharmacy data from a private
sector health information exchange firm
and laboratory data from two nationallevel private sector clinical laboratories.
The BioSense Program is in the
process of transitioning from the
original BioSense application to the
BioSense 2.0 application that has new
governance, a new organizational
structure, and a new process for data
submission and management. The
Association of State and Territorial
Health Officials (ASTHO) has been
funded through a cooperative agreement
with CDC’s Division of Notifiable
Disease and Healthcare Information
(DNDHI) within the Public Health
Surveillance and Informatics Program
Office (PHSIPO) of the Office of
Surveillance, Epidemiology, and
Laboratory Services (OSELS) to facilitate
the governance of BioSense 2.0, and
through a contract with a vendor,
ASTHO will offer access and use of
BioSense 2.0 on a voluntary basis to

PO 00000

Frm 00077

Fmt 4703

Sfmt 4703

state, local, and territorial health
jurisdictions.
Unlike the original BioSense
application where participating
organizations’ data were processed and
stored at CDC in the CDC owned and
operated Information Technology
Services Office’s Mid-Tier Data Center
on secure servers, all data submitted by
users in BioSense 2.0 will reside in a
cloud-enabled, web-based platform that
sits in the secure, private Government
Cloud and is in compliance with the
Federal Information Security
Management Act. The platform will
provide users with an exclusive secure
space as well as tools for posting,
receiving, controlling, analyzing, and
sharing their public health surveillance
information with other public health
jurisdictions, CDC, or other public
health partners. The public health
jurisdiction will retain ownership of any
data it contributes to its exclusive
secure space within BioSense 2.0.
The BioSense 2.0 cloud also provides
the CDC’s BioSense Program its own
exclusive secure space to receive, store,
and analyze data. CDC has agreements
with VA, DoD, two national-level
private sector clinical laboratories, and
a private sector health information
exchange firm to provide healthcare
encounter data to CDC’s secure space for
the purpose of national public health
situation awareness and syndromic
surveillance. These organizations
automatically chose to share with CDC
when they were recruited to submit data
to the BioSense 2.0 cloud environment.
Because they are not required to choose
sharing permissions, collecting already
existing healthcare encounter data
submitted via electronic record
transmission from them entails no
burden hours.
In addition to providing a secure,
exclusive space for use by CDC and
secure, exclusive spaces for use by each
participating state, local, and territorial
public health jurisdiction, BioSense 2.0
provides a second secure space in the
cloud for public health jurisdictions to
share aggregate data with other
participating jurisdictions and CDC.
Whenever possible, the BioSense

E:\FR\FM\06JNN1.SGM

06JNN1

33465

Federal Register / Vol. 77, No. 109 / Wednesday, June 6, 2012 / Notices
shared space for public health practice
and surveillance purposes.
In order to continue meeting the
congressional mandate in the BioSense
2.0 application, the BioSense Program
maintains 3 different types of
information collection: (1) Contact
information (name, telephone number,
email address, and street address)
needed for recruitment of up to 20
participating public health jurisdictions
to BioSense 2.0 per year; (2) one-time
collection of information (name, email
address, title, organizational affiliation,
security questions, and password) to
provide access to the BioSense 2.0 cloud
and its tools for all appropriate users in
participating jurisdictions and
organizations, and (3) collection of

Program plans to share aggregate-level
pharmacy and laboratory data with
public health jurisdictions. To
participate in the shared space,
jurisdiction administrators must simply
select from drop-down lists to choose
their sharing permissions on the
BioSense 2.0 application, and they will
have the right at any time to revise the
level of sharing permissions regarding
the data in their secure space.
As part of access to the shared space,
public health jurisdictions will be
required to grant CDC access to, at
minimum, aggregate level data (city,
county, or state) from their jurisdiction
that has been placed in the shared
space. They must also agree that CDC
may review data contributed to the

already existing healthcare encounter
data submitted to the cloud via
electronic record transmission from
participating public health jurisdictions’
non-federal hospitals, VA, DoD, two
national-level private sector clinical
laboratories, and a private sector health
information exchange firm. Though a
large number of electronic records are
transmitted from each entity each year,
once the automated interfaces are set up
for transmission (choosing sharing
permissions), there is no human burden
for record transmission.
This request is for a 3-year approval.
There are no costs to survey
respondents other than their time to
participate.

ESTIMATES OF ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent

Number of
respondents

Type of respondents

Average
burden per
response
(in hours)

Total burden
(in hours)

Recruitment
State, Local, and Territorial Public Health Jurisdictions ..................................
Federal Government ........................................................................................
Private Sector (national clinical laboratory corporations, and a private sector
health information exchange company) .......................................................

20
2

1
1

1
1

20
2

3

1

1

3

200
30
50

1
1
1

5/60
5/60
5/60

17
3
4

Access to BioSense 2.0 Application
State, Local, and Territorial Public Health Jurisdictions ..................................
Federal Government ........................................................................................
Private Sector ..................................................................................................

Data Collection: Administrator Sharing Permissions
State, Local, and Territorial Public Health Jurisdictions ..................................
Federal Government ........................................................................................
Private Sector (national clinical laboratory corporations, and a private sector
health information exchange company) .......................................................

20
2

1
0

5/60
0

2
0

3

0

0

0

Total ..........................................................................................................

........................

........................

........................

51

Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–13689 Filed 6–5–12; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

mstockstill on DSK4VPTVN1PROD with NOTICES

Centers for Disease Control and
Prevention
[60Day–12–0822]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the

VerDate Mar<15>2010

17:24 Jun 05, 2012

Jkt 226001

Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the

PO 00000

Frm 00078

Fmt 4703

Sfmt 4703

proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Intimate Partner and Sexual
Violence Surveillance System (OMB No.
0920–0822, exp. 09/30/2012)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).

E:\FR\FM\06JNN1.SGM

06JNN1